Lifordi Immunotherapeutics: Funding, Investors & Team (Sep 2026)
Lifordi Immunotherapeutics is a biotech company that provides antibody-drug conjugates for autoimmune and inflammatory disorders.
Lifordi Immunotherapeutics has raised $42.0M across 1 funding round on record, the most recent an undisclosed round of $42.0M announced in Nov 2025.
That round is in line with the $42M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Lifordi Immunotherapeutics Company Profile and Key Stats
Latest funding round on record: Nov 2025.
Lifordi Immunotherapeutics Funding Rounds
Lifordi Immunotherapeutics Founders and Leadership Team
Contact details for the Lifordi Immunotherapeutics team: 1 of 1 has an email address on file, 1 has a LinkedIn profile.
Start 14-day free trial →Lifordi Immunotherapeutics Funding Compared to Other Biotechnology Startups
Lifordi Immunotherapeutics' latest round of $42.0M is in line with the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Lifordi Immunotherapeutics in Biotechnology and Burlington
Companies Similar to Lifordi Immunotherapeutics
Crystalys Therapeutics is a clinical-stage biopharmaceutical company transforming the treatment of gout.
Solve Therapeutics is a biopharmaceutical company that develops Antibody Drug Conjugate and Bispecific…
Artizan Biosciences focuses on drug discovery and development for diseases involving the human intestinal…
Neok Bio is a biotech startup that focuses on bispecific ADCs in cancer therapy.
TORL BioTherapeutics is a clinical-stage biopharmaceutical business.
ThirdLaw Molecular pioneers revolutionary Spiroligomer™ molecules for safer, more targeted, effective disease…
Aerska is a biotechnology company that is creating RNA medications to treat, postpone, and prevent brain…
Weike Bio is a gene therapy drug development company.
Twinpig Biolab researches and develops anticancer drugs.
Kunshi Biotechnology is a drug developer with an emphasis on solid tumor cells.
BOOST Pharma develops a stem cell therapy for the treatment of osteogenesis imperfecta.
Step Pharma is a biotechnology company.
Lifordi Immunotherapeutics Funding FAQs
What does Lifordi Immunotherapeutics do?
Lifordi Immunotherapeutics is a biotech company that provides antibody-drug conjugates for autoimmune and inflammatory disorders.
How much funding has Lifordi Immunotherapeutics raised?
Lifordi Immunotherapeutics has raised $42.0M across 1 round on record. The most recent is an undisclosed round of $42.0M announced in Nov 2025.
When did Lifordi Immunotherapeutics last raise funding?
Lifordi Immunotherapeutics' most recent funding round on record is an undisclosed round of $42.0M, announced in Nov 2025.
Where is Lifordi Immunotherapeutics headquartered?
Lifordi Immunotherapeutics is based in Burlington, United States.
How many employees does Lifordi Immunotherapeutics have?
Lifordi Immunotherapeutics is in the 11-50 employee band.
How does Lifordi Immunotherapeutics' funding compare to other Biotechnology startups?
Lifordi Immunotherapeutics' latest round of $42.0M is in line with the $42M median round size for Biotechnology companies on FundedIQ across 20 tracked companies over the last two years.
About FundedIQ's Lifordi Immunotherapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Lifordi Immunotherapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.